In melanoma, the increased PDE4B2 expression was observed compared with that in melanocyte and PDE4B2 expression is necessary to transform melanocyte with oncogenic NRAS [15], implicating the effective strategy for cancer treatment by targeting the PDE4B2. This evidence concerns the gene NRAS and cancer.